Lv1
50 积分 2022-10-26 加入
A high‐fidelity, dual site‐specific integration system in CHO cells by a Bxb1 recombinase
12小时前
已完结
A genetic off-target event in a site-specific integration cell line expressing monoclonal antibody has no impact on commercial suitability
8个月前
已完结
CHO synthetic promoters improve expression and product quality of biotherapeutic proteins
2年前
已完结
A ribonucleoprotein-based decaplex CRISPR/Cas9 knockout strategy for CHO host engineering
2年前
已完结
皖公网安备34019202002308
